Covered recipient · General Payments record
PAUL S CHARD
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$4,491.16
- Reported across 204 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $562.93 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $243.96 | 14 |
| Lilly USA, LLC | $84.14 | 3 |
| QOL Medical, LLC | $79.42 | 4 |
| Celgene Corporation | $46.67 | 3 |
| Regeneron Healthcare Solutions, Inc. | $23.06 | 1 |
| Janssen Biotech, Inc. | $22.10 | 1 |
| Acerta Pharma LLC | $21.76 | 1 |
| Phathom Pharmaceuticals, Inc. | $21.73 | 1 |
| PFIZER INC. | $20.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.21 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103445520 | CMS |
| ABBVIE INC. | $17.86 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103445522 | CMS |
| ABBVIE INC. | $19.66 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103445524 | CMS |
| ABBVIE INC. | $25.80 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103445526 | CMS |
| ABBVIE INC. | $15.21 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103445528 | CMS |
| ABBVIE INC. | $1.98 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103445530 | CMS |
| ABBVIE INC. | $16.03 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103445532 | CMS |
| ABBVIE INC. | $0.73 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103445534 | CMS |
| ABBVIE INC. | $23.10 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103445536 | CMS |
| ABBVIE INC. | $5.49 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103445538 | CMS |
| ABBVIE INC. | $18.06 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103445540 | CMS |
| ABBVIE INC. | $14.48 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103445542 | CMS |
| ABBVIE INC. | $32.20 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103445544 | CMS |
| ABBVIE INC. | $28.15 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103445546 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.76 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104572550 | CMS |
| Celgene Corporation | $17.95 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101197958 | CMS |
| Celgene Corporation | $13.71 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101197966 | CMS |
| Celgene Corporation | $15.01 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101197964 | CMS |
| Janssen Biotech, Inc. | $22.10 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078314326 | CMS |
| Lilly USA, LLC | $28.85 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135272572 | CMS |
| Lilly USA, LLC | $29.16 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135265380 | CMS |
| Lilly USA, LLC | $26.13 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135310851 | CMS |
| PFIZER INC. | $20.09 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131442059 | CMS |
| Phathom Pharmaceuticals, Inc. | $21.73 | 06/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151048118 | CMS |
| QOL Medical, LLC | $20.83 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147718607 | CMS |
| QOL Medical, LLC | $20.94 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147718609 | CMS |
| QOL Medical, LLC | $21.27 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147718611 | CMS |
| QOL Medical, LLC | $16.38 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147718613 | CMS |
| Regeneron Healthcare Solutions, Inc. | $23.06 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114022192 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.